Tasly Pharmaceutical Group Co Ltd

Price Chart

Risk-Adjusted Performance

Tasly Pharmaceutical Group Co Ltd (600535) Price Performance

Tasly Pharmaceutical Group Co Ltd (600535) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY14.25, down 1.18% from the previous close.

Over the past year, 600535 has traded between a low of CNY13.63 and a high of CNY17.41. The stock has lost 6.7% over this period. It is currently 18.2% below its 52-week high.

Tasly Pharmaceutical Group Co Ltd has a market capitalization of $21.29B, with a price-to-earnings ratio of 19.26 and a dividend yield of 2.15%.

About Tasly Pharmaceutical Group Co Ltd

Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities. The company was formerly known as Tianjin Tasly Pharmaceutical Co., Ltd. and changed its name to Tasly Pharmaceutical Group Co., Ltd in May 2012. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is headquartered in Tianjin, China.